Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn’s disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) trial - Panaccione, R; Loftus, E V, Jr; Binion, D (Can J Gastroenterol, 2011)
et al.